SenoRx gains FDA approval for breast biopsy ultrasound system

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon
The FDA has granted 501(k) clearance to SenoRx for its SenoSonix System, which is an integration of its EnCor breast biopsy system with an ultrasound imaging system from Ultrasonix Medical of Richmond, British Columbia.

The product will be branded as SenoSonix and marketed as SenoSonix with EnCor Inside, according to the Aliso Viejo, Calif.-based SenoRx.